Netherlands· NL-eed338e18c85
Cystadrops 3,8 mg/ml oogdruppels, oplossing
A mercaptamine product containing mercaptaminehydrochloride, registered in Netherlands by Orphan Europe SARL. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 13 of 19 countries.
Countries holding a registration under ATC S01XA21 (mercaptamine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Mercaptamine · ATC S01XA21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MERCAPTAMINEHYDROCHLORIDE
- Manufacturer
- Orphan Europe SARL
- Country
- Netherlands (NL)
- ATC code
- S01XA21
- ATC class
- Mercaptamine
- Defined daily dose
- 0.4 ml, AT
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/15/1049
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCYSTADROPSRecordati Rare Diseases, Puteaux
- SwitzerlandCystadrops 3.8 mg/ml, AugentropfenRECORDATI AG
- FinlandCystadropsRecordati Rare Diseases
- FranceCYSTADROPS 3,8 mg/mL, collyre en solutionRECORDATI RARE DISEASES
- IrelandCystadrops 3.8 mg/mL eye drops solutionRecordati Rare Diseases
- IcelandCYSTADROPSRecordati Rare Diseases*
- NorwayCystadropsRecordati Rare Diseases
- PolandCystadropsRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9276704-d4b1-46c9-9bfb-17ecab426660 GET /v1/drugs/b9276704-d4b1-46c9-9bfb-17ecab426660?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/cystadrops-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Mercaptamine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp116312",
"excipients": [
"BENZALKONIUMCHLORIDE",
"CARMELLOSE NATRIUM (E 466)",
"CITROENZUUR 1-WATER (E 330)",
"DINATRIUMEDETAAT 2-WATER",
"NATRIUMHYDROXIDE (E 524)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"MERCAPTAMINEHYDROCHLORIDE"
],
"leaflet_url": null,
"authorised_at": "2016/10/13",
"procedure_number": "EMEA/H/C/003769",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/15/1049",
"additional_monitoring": "N"
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.